Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Novo Nordisk Foundation establishes fellowships with four top international universities


News provided by

Novo Holdings

11 Oct, 2022, 06:53 GMT

Share this article

Share toX

Share this article

Share toX

COPENHAGEN, Denmark, Oct. 11, 2022 /PRNewswire/ -- The Novo Nordisk Foundation is expanding and extending its Interdisciplinary Postdoctoral Fellowship Programme, thereby enabling ambitious researchers in the natural and technical sciences and life sciences to boost their careers with a research stay at one of several top international universities.

The Novo Nordisk Foundation wants to give researchers in Denmark the opportunity to seek inspiration and acquire new knowledge and skills by supporting their research stays at top international research institutions. To facilitate this, the Foundation has just entered into strategic partnerships with several internationally leading research actors. This especially benefits the Foundation's Interdisciplinary Postdoctoral Fellowship Programme. A new programme budget of DKK 96 million over a 3-year period will boost the Programme while offering attractive fellowships with improved benefits and research opportunities at one of these top international universities.

The Foundation launched the Interdisciplinary Postdoctoral Fellowship Programme in 2015 through collaboration with Stanford Bio-X (USA). The fruitful experience has led to the expansion of the Programme, and the decision of the Foundation to establishing collaboration agreements with Massachusetts Institute of Technology (MIT, USA), the University of Oxford (United Kingdom) and the Weizmann Institute of Science (Israel), in addition to Stanford Bio-X.

The purpose of the Programme is to boost the professional and personal development of talented researchers through 3 years of international experience and networking in a world-leading research community. In addition to the career-promoting aspect for the individual researcher, the Programme has the additional benefit that it facilitates the researcher's reintegration into the Danish research environment by supporting the fourth and final year of the project period at their affiliated university in Denmark and thus brings back innovation, networks and experience.

In addition, the Programme promotes building human bridges and valuable relationships between Danish and international universities. The new expansion builds on the success of the Programme so far.

Lene Oddershede, Senior Vice President, Natural & Technical Sciences, Novo Nordisk Foundation, says: "At the Novo Nordisk Foundation, we want to promote quality research and innovation at the highest international level and to bring novel research expertise to Denmark. We have had really good experience in sending young researchers to Stanford University, and we therefore want to expand the mobility opportunities with more top international universities. This is an investment in the growth layer of researchers in Denmark who will contribute positively to research and development in the future."

"Internationalisation leads to increased creativity and creates innovation and value in research communities in Denmark. However, young researchers can face practical challenges when travelling abroad; finances can especially be a barrier for researchers with families and children. We seek to remedy this by covering health insurance costs, both for the fellows and their family and for example, by subsidising childcare costs in the programme at MIT. Thus, pursuing the dream of obtaining international research experience at a leading university will become more attractive and realistic, also for young researchers with families," adds Lene Oddershede.

Innovative research communities

"The Interdisciplinary Postdoctoral Fellowship Programme will promote building bridges between Danish and international universities and thus help to lay the foundations for making it easier for researchers in Denmark to seek experience outside Denmark in the future, but also the other way around. Therefore, another ambition is that the Programme acts as a branding of Danish research," explains Mikkel Skovborg, Senior Vice President, Innovation, Novo Nordisk Foundation.

"Denmark has a long and proud tradition of world-class research, and although many research communities recognise this already, we think that a new initiative boosting researchers in Denmark will be of great benefit. We hope to pave the way for a future where even more meaningful exchange programmes can be established across national borders and researchers in Denmark can obtain access to innovative research communities abroad. This has been a key factor in deciding which universities the Foundation should include in the Programme," says Mikkel Skovborg, adding that:

"The four universities that are now part of the Programme are all internationally recognised for their high level of interdisciplinarity and for their innovative approach to research and development. This means that the grant recipients will be able to conduct research in an exceptionally educational and fruitful environment and hopefully achieve exciting new breakthroughs in their research."

An important aspect of the new version of the Programme is that, after the grant ends, the recipients can apply for a proof-of-concept grant that will enable them to exploit translation of their discovery or invention to eventual commercialisation in Denmark.

Selection criteria

Before applying for a Fellowship Programme grant, applicants must meet the following criteria:

  • The applicant will have obtained a PhD within 5 years of the fellowship start date.
  • The applicant must have a solid education in the natural sciences, the technical sciences or the life sciences.
  • The applicant must have established contact with a faculty member at one of the four hosting universities, who has committed to being the primary research mentor for the duration of the fellowship.
  • The applicant must have had significant association to Denmark's educational system or a research community in Denmark, such as by having graduated from a university in Denmark, and a clear intention of returning to Denmark after the stay abroad.
  • Applicants must confirm that a university in Denmark will host the researcher when they return to Denmark, which also entails employing the fellow during the grant period and administering the grant.

Read more about the application process here: Fellowships at MIT, Fellowships at Stanford Bio-X, Fellowships at University of Oxford and Fellowships at Weizmann Institute of Science.

About the Novo Nordisk Foundation

Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives. The vision of the Foundation is to improve people's health and the sustainability of society and the planet. The Foundation's mission is to progress research and innovation in the prevention and treatment of cardiometabolic and infectious diseases as well as to advance knowledge and solutions to support a green transformation of society.

www.novonordiskfonden.dk/en

Modal title

Also from this source

Novo Holdings portfolio company Kate Farms acquired by Danone

Novo Holdings, a leading life science investor, today announced that its portfolio company Kate Farms has been acquired by Danone, a global leader in ...

Novo Holdings appoints four new members to its Board of Directors further strengthening global perspectives and strategic capabilities

Novo Holdings is pleased to announce the appointments of Jun Sung Kim, Lars Green, N.P. "Narv" Narvekar and Torsten Sløk to its Board of Directors,...

More Releases From This Source

Explore

Education

Education

Health Care & Hospitals

Health Care & Hospitals

Computer & Electronics

Computer & Electronics

STEM (Science, Tech, Engineering, Math)

STEM (Science, Tech, Engineering, Math)

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.